{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:42:10Z","timestamp":1789753330048,"version":"4.0.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Autoimmune encephalitis is a neurological condition caused by abnormal immune responses, manifesting as cognitive impairments, behavioral abnormalities, and seizures. Its diagnosis depends on the detecting neuronal surface antibodies in serum or cerebrospinal fluid. Despite recent advances in understanding, clinical recognition remains challenging, especially with rare antibodies such as anti-dopamine D2 receptor (D2R) and anti-dipeptidyl-peptidase-like protein 6 (DPPX) antibodies. Delayed diagnosis can lead to severe complications. This case presentation emphasizes the diagnostic intricacies and effective treatment of the anti-D2R and DPPX antibody-associated autoimmune encephalitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>The patient presented with a 3-day history of fatigue and limb soreness followed by a 3-h episode of confusion and limb convulsions. Upon admission to our facility, the initial diagnosis included status epilepticus, aspiration pneumonia, metabolic acidosis, respiratory alkalosis, and suspected encephalitis. Despite receiving antiepileptic, anti-infection, and antivirus therapy, the patient\u2019s condition deteriorated. Both computed tomography (CT) scan and magnetic resonance imaging (MRI) of the brain showed no significant abnormalities. No pathogen was identified in the cerebrospinal fluid (CSF). However, further CSF and serum examination revealed positive results of anti-D2R and anti-DPPX antibodies, confirming a diagnosis of anti-D2R and DPPX antibody-associated autoimmune encephalitis. The patient underwent a comprehensive treatment regimen, including high-dose methylprednisolone pulse therapy combined with intravenous immunoglobulin (IVIG), antiviral and anti-infection treatments, and antiepileptic medications. Significant clinical improvement was observed, and by the 18th day of admission, the patient was stable and coherent.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The current patient represents the first reported case of double-positive autoimmune encephalitis for anti-D2R and DPPX antibodies, with epilepsy as a prominent feature. High-dose methylprednisolone pulse therapy combined with IVIG has shown significant safety and efficacy in treating anti-D2R and DPPX antibody-positive autoimmune encephalitis-associated epilepsy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1338714","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T04:39:10Z","timestamp":1708922350000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhangliang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiye","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangman","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.4154","article-title":"Autoimmune encephalitis-misdiagnosis, misconceptions, and how to avoid them","volume":"80","author":"Dalmau","year":"2023","journal-title":"JAMA Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5086","article-title":"Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis","volume":"38","author":"Kelley","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/WCO.0000000000001048","article-title":"Immunotherapy in autoimmune encephalitis","volume":"35","author":"Trewin","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/1871527319666200708133103","article-title":"Autoimmune encephalitis: current knowledge on subtypes, disease mechanisms and treatment","volume":"19","author":"Nissen","year":"2020","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/IJGM.S397429","article-title":"Anti-NMDA receptor autoimmune encephalitis: diagnosis and management strategies","volume":"16","author":"Nguyen","year":"2023","journal-title":"Int J Gen Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.866074","article-title":"Autoimmune encephalitis and other neurological syndromes with rare neuronal surface antibodies in children: A systematic literature review","volume":"10","author":"Ancona","year":"2022","journal-title":"Front Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"103118","DOI":"10.1016\/j.autrev.2022.103118","article-title":"Rare antibody-mediated and seronegative autoimmune encephalitis: An update","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/apha.12614","article-title":"Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond","volume":"216","author":"Cunningham","year":"2016","journal-title":"Acta Physiol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14613","article-title":"Anti-dopamine D2 receptor antibodies in chronic tic disorders","volume":"62","author":"Addabbo","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e73516","DOI":"10.1371\/journal.pone.0073516","article-title":"Dopamine receptor autoantibodies correlate with symptoms in Sydenham\u2019s chorea","volume":"8","author":"Ben-Pazi","year":"2013","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/diagnostics13152589","article-title":"Autoimmune encephalitis with antibodies: anti-NMDAR, anti-AMPAR, anti-GQ1b, anti-DPPX, anti-CASPR2, anti-LGI1, anti-RI, anti-yo, anti-hu, anti-CV2 and anti-GABAAR, in the course of psychoses, neoplastic diseases, and paraneoplastic syndromes","volume":"13","author":"Braczkowski","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12883-022-02649-7","article-title":"Clinical and imaging analysis to evaluate the response of patients with anti-DPPX encephalitis to immunotherapy","volume":"22","author":"Xiao","year":"2022","journal-title":"BMC Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001088","article-title":"Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry","volume":"8","author":"Thaler","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlz128","article-title":"Intranasal methylprednisolone effectively reduces neuroinflammation in mice with experimental autoimmune encephalitis","volume":"79","author":"Rassy","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51540","article-title":"The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis","volume":"9","author":"Lee","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-021-10004-9","article-title":"The role of plasma exchange in the treatment of refractory autoimmune neurological diseases: a narrative review","volume":"16","author":"Jacob","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1240089","article-title":"Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1338714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T04:39:12Z","timestamp":1708922352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1338714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2024.1338714"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1338714","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"article-number":"1338714"}}